ATE276272T1 - Entzündungshemmende peptide - Google Patents

Entzündungshemmende peptide

Info

Publication number
ATE276272T1
ATE276272T1 AT94921322T AT94921322T ATE276272T1 AT E276272 T1 ATE276272 T1 AT E276272T1 AT 94921322 T AT94921322 T AT 94921322T AT 94921322 T AT94921322 T AT 94921322T AT E276272 T1 ATE276272 T1 AT E276272T1
Authority
AT
Austria
Prior art keywords
peptides
inflammatory peptides
peptide
pharmaceutical compositions
methods
Prior art date
Application number
AT94921322T
Other languages
English (en)
Inventor
David F Counts
Ronald G Duff
Original Assignee
Curative Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curative Tech Inc filed Critical Curative Tech Inc
Application granted granted Critical
Publication of ATE276272T1 publication Critical patent/ATE276272T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94921322T 1993-06-18 1994-06-17 Entzündungshemmende peptide ATE276272T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8037193A 1993-06-18 1993-06-18
PCT/US1994/006888 WO1995000543A1 (en) 1993-06-18 1994-06-17 Anti-inflammatory peptides

Publications (1)

Publication Number Publication Date
ATE276272T1 true ATE276272T1 (de) 2004-10-15

Family

ID=22156955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94921322T ATE276272T1 (de) 1993-06-18 1994-06-17 Entzündungshemmende peptide

Country Status (7)

Country Link
EP (1) EP0714404B1 (de)
JP (1) JP3645905B2 (de)
AT (1) ATE276272T1 (de)
AU (1) AU7209594A (de)
CA (2) CA2165418C (de)
DE (1) DE69433999T2 (de)
WO (1) WO1995000543A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0838226B1 (de) * 1995-07-10 2005-09-21 ASAHI MEDICAL Co., Ltd. Extrakorporaler blutkreislauf für die heilung entzündlicher krankheiten
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
CA2704724A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag 5use of a peptide as a therapeutic agent
EP2229951A1 (de) 2009-03-08 2010-09-22 Stichting Katholieke Universiteit Verfahren zur Behandlung oder Vorbeugung von systemischer Sklerose
CN112759634B (zh) * 2021-01-21 2022-04-08 浙江辉肽生命健康科技有限公司 具有氨基酸结构feyieenky的生物活性肽及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5480869A (en) * 1990-01-09 1996-01-02 The Regents Of The University Of California Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues
JP3159705B2 (ja) * 1990-12-21 2001-04-23 キュラティブ テクノロジーズ，インコーポレーテッド 血管形成ペプチド
US5482930A (en) * 1993-06-09 1996-01-09 The Regents Of The University Of California Anti-inflammatory composition and method with des-Tyr dynorphin and analogues

Also Published As

Publication number Publication date
WO1995000543A1 (en) 1995-01-05
CA2568107A1 (en) 1995-01-05
DE69433999T2 (de) 2005-09-22
JPH09501415A (ja) 1997-02-10
EP0714404A1 (de) 1996-06-05
AU7209594A (en) 1995-01-17
CA2165418C (en) 2007-03-13
EP0714404A4 (de) 1999-02-10
CA2568107C (en) 2011-06-14
DE69433999D1 (de) 2004-10-21
EP0714404B1 (de) 2004-09-15
CA2165418A1 (en) 1994-12-19
JP3645905B2 (ja) 2005-05-11

Similar Documents

Publication Publication Date Title
FI956310L (fi) Stabiloidut farmaseuttiset peptidikoostumukset
ID17863A (id) Komposisi-komposisi farmasi yang terdiri dari siklosporin
ES2107357A1 (es) Sales de peptidos con poliesteres carboxi-terminados.
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
NO20061455L (no) 2,6 dioksopiperidin samt farmasoytiske preparater som inneholder disse
ZA98214B (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.
ATE204297T1 (de) Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
ATE245977T1 (de) Therapeutische substituierte guanidine
RU95106674A (ru) Полиеновые соединения, фармацевтическая и косметическая композиция на их основе
MX9207394A (es) Esteroides de 17-espirofuran-3'-ilideno.
FI943261L (fi) Farmaseuttiset bakteriosiinikoostumukset
NO980296D0 (no) Forbedrede terapeutiske midler
DE69433999D1 (de) Entzündungshemmende peptide
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9400072A (es) Agentes antiinflamatorios derivados de difluoropentapeptido.
RU95109891A (ru) 19,11-перекрытые мостиками 4-эстрены, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения для их получения
IT7850967A0 (it) Composti peptidici derivati da glicina loro procedimento di produzione e composizioni farmaceutiche cheli contengono
IT1277338B1 (it) Composizioni farmaceutiche di ciclosporina o altre sostanze peptidiche
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi
GR1002385B (el) Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν.
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IT1270976B (it) Composti inibitpri di acil enzima-a-colesterolo-o-acil transferasi ad attivita' terapeutica, loro uso e composizioni farmaceutiche che li contengono
ITMI922332A0 (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale
BR1100310A (pt) Peptìdeo, composto e composição farmacêutica

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties